This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a specialty hepatitis B vaccine. The ceiling value of the firm-fixed-price contract is $15,985.25, with a period of performance through November 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that broader IDC, demonstrating the company's role as a key vendor supporting the medical needs of the U.S. military and veterans. There was no specific set-aside designation for this award.
Generated 2/19/25, 9:13 AM